Link to this page
Medical Subject Headings
| Preferred Name | Erlotinib Hydrochloride | |
| Synonyms |
HCl, Erlotinib 11C-erlotinib Erlotinib OSI774 OSI 774 Tarceva CP-358,774 Erlotinib HCl CP358774 CP 358774 CP 358,774 358,774, CP 11C erlotinib Hydrochloride, Erlotinib 358774, CP CP358,774 CP-358774 OSI-774 N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine |
|
| Definitions |
A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000069347 |
|
| altLabel |
HCl, Erlotinib 11C-erlotinib Erlotinib OSI774 OSI 774 Tarceva CP-358,774 Erlotinib HCl CP358774 CP 358774 CP 358,774 358,774, CP 11C erlotinib Hydrochloride, Erlotinib 358774, CP CP358,774 CP-358774 OSI-774 N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C1135137 C0910101 C1533491 C3886651 C1135135 C1135136
|
|
| DC |
1
|
|
| definition |
A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.
|
|
| DX |
20160101
|
|
| HN |
2016 (1999)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
J4T82NDH7E DA87705X9K 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2016; ERLOTINIB HYDROCHLORIDE was indexed under QUINAZOLINES 1999-2015
|
|
| MDA |
20150710
|
|
| MMR |
20230804
|
|
| MN |
D03.633.100.786.375
|
|
| notation |
D000069347
|
|
| PA |
D000092004 D000970
|
|
| prefLabel |
Erlotinib Hydrochloride
|
|
| RR |
J4T82NDH7E DA87705X9K 183319-69-9
|
|
| TERMUI |
T400569 T400567 T470797 T765851 T000879622 T509893 T000879623 T000866248 T400568 T000879621 T400566
|
|
| TH |
NLM (2002) NLM (1999) FDA SRS (2013) NLM (2001) USAN (19XX) INN (19XX) NLM (2003) NLM (2013) NLM (2010) NLM (2006) NLM (2014)
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |